8-K: Molina Healthcare Q1 2026 Results and Guidance Reaffirmed

Molina Healthcare reported Q1 2026 adjusted EPS of $2.35 and reaffirmed its full-year 2026 adjusted earnings guidance of at least $5.00 per share.

Summary

• Reported Q1 2026 GAAP net income of $14 million ($0.27 per diluted share) and adjusted net income of $120 million ($2.35 per diluted share).
• Premium revenue for the quarter was $10.2 billion, a 4% year-over-year decrease.
• Total membership stands at approximately 5.0 million members as of March 31, 2026.
• Consolidated Medical Care Ratio (MCR) was 91.1% for the first quarter.
• Reaffirmed full-year 2026 guidance for premium revenue of approximately $42 billion and adjusted earnings of at least $5.00 per diluted share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral report; while the company met expectations and reaffirmed guidance, the significant year-over-year decline in GAAP earnings and revenue highlights ongoing structural challenges in the Medicaid and Marketplace segments.

Positives

• Operating cash flow increased significantly to $1,082 million in Q1 2026 compared to $190 million in Q1 2025.
• Medical cost trends were reported as moderately favorable to company expectations.
• Maintained a disciplined approach to medical cost management despite market headwinds.
• Successfully implemented pricing and benefit adjustments for the 2026 Medicare segment.

Negatives

• GAAP net income declined 95% year-over-year, largely due to a $93 million impairment charge.
• Premium revenue decreased 4% year-over-year, driven by Medicaid membership contraction and a strategic reduction in Marketplace membership.
• Adjusted net income per diluted share fell 61% compared to the same period in 2025.
• Consolidated MCR increased to 91.1% from 89.2% in the prior year period.

Risks

• Planned exit from the Medicare Advantage-Part D product for 2027, resulting in a $93 million impairment charge.
• General market contraction in Medicaid membership.
• Expiration of the Medicaid contract in Virginia.
• Ongoing regulatory and program integrity initiatives by the Centers for Medicare and Medicaid Services impacting Marketplace MCR.
• Sensitivity to medical cost trends and utilization rates.

Future Outlook

The company reaffirmed its full-year 2026 guidance, expecting premium revenue of approximately $42 billion and adjusted earnings of at least $5.00 per diluted share. Management plans to update this guidance during the Q2 2026 earnings report to incorporate first-half performance.

Management Comments

• We are pleased with our first quarter results and continued disciplined approach to medical cost management.
• Medical cost trend was modestly favorable to our expectations.
• Our reaffirmed full year 2026 premium revenue and adjusted earnings guidance reflect a prudent view of full year results at this early point in the year.

Industry Context

StockSavvy.ai notes that Molina Healthcare is navigating a challenging environment characterized by Medicaid redeterminations and a strategic pivot away from certain Medicare Advantage products. The company's focus on 'dual eligible' members aligns with broader industry trends where insurers are narrowing their focus to high-acuity, government-sponsored populations to improve margins.

Comparison to Industry Standards

• Molina's MCR of 91.1% reflects the broader industry pressure on medical costs, comparable to peers like Centene or Elevance Health who are also managing Medicaid rate cycles.
• The strategic exit from Medicare Advantage-Part D is consistent with industry-wide re-evaluations of MA profitability in light of CMS regulatory changes.

Stakeholder Impact

• Shareholders: Impacted by the significant decline in quarterly GAAP earnings and the impairment charge.
• Customers: Potential changes in service offerings as the company shifts focus toward dual-eligible members.
• Employees: Potential organizational shifts related to the planned exit from the Medicare Advantage-Part D product.

Next Steps

• Host conference call on April 23, 2026.
• Hold Investor Day event on May 8, 2026, to discuss three-year outlook.
• Update full-year 2026 guidance during the Q2 2026 earnings report.

Key Dates

Recommendation

The stock is a hold as the company is in a transition phase, exiting non-core Medicare products while managing through Medicaid membership contraction. Investors should wait for the Investor Day update on May 8th to gain clarity on the three-year growth strategy before increasing positions.

Keywords

Molina Healthcare, MOH, Managed Healthcare, Medicaid, Medicare Advantage, Earnings Report, Medical Care Ratio, Health Insurance